AI assistant
Sending…
CEL SCI CORP — Director's Dealing 2017
Nov 6, 2017
34401_dirs_2017-11-06_3b238484-4263-409f-a5c6-1affad835690.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: CEL SCI CORP (cvm)
CIK: 0000725363
Period of Report: 2017-11-02
Reporting Person: KERSTEN GEERT R (Director, Chief Executive Officer)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2017-11-02 | Series RR Warrants | $1.65 | A | 54585 | Acquired | 2022-10-30 | Common Stock (54585) | Indirect |
| 2017-11-02 | Series RR Warrants | $1.65 | A | 73965 | Acquired | 2022-10-30 | Common Stock (73965) | Direct |
Footnotes
F1: In consideration for extending the maturity date of the Convertible Notes sold in June and July 2017, the Company issued the note holders that agreed to the extension Series RR warrants.
F2: A trust in which Mr. Kersten holds a beneficial interest participated in the offering in July 2017.
More from CEL SCI CORP
Interim / Quarterly Report
2026
May 15
Regulatory Filings
2026
May 14
Regulatory Filings
2026
May 13
Regulatory Filings
2026
May 13
Regulatory Filings
2026
May 12
Regulatory Filings
2026
May 1
Regulatory Filings
2026
Apr 24
Regulatory Filings
2026
Apr 17
Interim / Quarterly Report
2026
Feb 17
Director's Dealing
2026
Jan 26